Screener
Outlook Therapeutics, Inc. OTLK Q3 2025 Annual earnings
Reported December 19, 2025 · Before market open
Revenue-$91.8KMiss by $5.9M
EPS-$0.22Beat by $0.04
Revenue estimate$5.8M
EPS estimate-$0.26
Next report
Date not yet announcedVersus estimates
Revenue
Q2 2026$9.0KMiss by $957.7KQ1 2026$128.0KMiss by $4.3MQ4 2025-$1.2MMiss by $4.4M
Q3 2025-$91.8KMiss by $5.9M
Q2 2025$1.5MMiss by $4.3MDiluted EPS
FAQ
- When did Outlook Therapeutics, Inc. report Q3 2025 earnings?
- Outlook Therapeutics, Inc. (OTLK) reported Q3 2025 earnings on December 19, 2025 before market open.
- What were Outlook Therapeutics, Inc.'s Q3 2025 revenue and EPS?
- Outlook Therapeutics, Inc. reported revenue of -$91.8K and eps of $-0.22 for Q3 2025.
- Did Outlook Therapeutics, Inc. beat estimates in Q3 2025?
- Revenue missed the consensus estimate of $5.8M by $5.9M. EPS beat the consensus estimate of $-0.26 by $0.04.
- How did Outlook Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 71.4% from $-0.77.
- Where can I find Outlook Therapeutics, Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001104659-25-122786) and the 10-K periodic report (0001104659-25-123264) directly on SEC EDGAR. The filing index links above go to sec.gov.
